Physics-driven identification of clinically approved and investigation drugs against human neutrophil serine protease 4 (NSP4): A virtual drug repurposing study - Publikacja - MOST Wiedzy

Wyszukiwarka

Physics-driven identification of clinically approved and investigation drugs against human neutrophil serine protease 4 (NSP4): A virtual drug repurposing study

Abstrakt

Neutrophils synthesize four immune associated serine proteases: Cathepsin G (CTSG), Elastase (ELANE), Proteinase 3 (PRTN3) and Neutrophil Serine Protease 4 (NSP4). While previously considered to be immune modulators, overexpression of neutrophil serine proteases correlates with various disease conditions. Therefore, identifying novel small molecules that can potentially control or inhibit the proteolytic activity of these proteases is crucial to revert or temper the aggravated disease phenotype. To the best of our knowledge, although there is limited data for inhibitors of other neutrophil protease members, there is no previous clinical study of a synthetic small molecule inhibitor targeting NSP4. In this study, an integrated molecular modeling algorithm was performed within a virtual drug repurposing study to identify novel inhibitors for NSP4, using clinically approved and investigation drugs library (∼8000 compounds). Based on our rigorous filtration, we found that following molecules Becatecarin, Iogulamide, Delprostenate and Iralukast are predicted to block the activity of NSP4 by interacting with core catalytic residues. The selected ligands were energetically more favorable compared to the reference molecule. The result of this study identifies promising molecules as potential lead candidates.

Cytowania

  • 3

    CrossRef

  • 1

    Web of Science

  • 0

    Scopus

Autor (1)

Cytuj jako

Pełna treść

pełna treść publikacji nie jest dostępna w portalu

Słowa kluczowe

Informacje szczegółowe

Kategoria:
Inna publikacyjna praca zbiorowa (w tym materiały konferencyjne)
Typ:
Inna publikacyjna praca zbiorowa (w tym materiały konferencyjne)
Tytuł wydania:
Journal of Molecular Graphics and Modelling
Rok wydania:
2020
Opis bibliograficzny:
Ahmad, J., Ikram, S., Hafeez, A. B., & Durdagi, S. (2020). Physics-driven identification of clinically approved and investigation drugs against human neutrophil serine protease 4 (NSP4): A virtual drug repurposing study. Journal of Molecular Graphics and Modelling, 101, 107744
DOI:
Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.1016/j.jmgm.2020.107744
Weryfikacja:
Brak weryfikacji

wyświetlono 1 razy

Publikacje, które mogą cię zainteresować

Meta Tagi